Use of a Dilatable exGraft Conduit in Single-Ventricle Palliation

Asad Qadir; Paul Tannous; Elizabeth H. Stephens; Arush Kalra; Joseph M. Forbess; Alan Nugent

doi:10.1016/j.athoracsur.2019.12.024

Use of a Dilatable exGraft Conduit in Single-Ventricle Palliation

Asad Qadir^*, Paul Tannous, Elizabeth H. Stephens, Arush Kalra, Joseph M. Forbess, Alan Nugent

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Surgically paced prosthetic conduits are commonly used in the treatment of congenital heart disease. A major limitation of available prosthetic grafts is that they do not grow with the patient. We describe a human case of percutaneous balloon dilation of a surgically placed exGraft conduit (PECA Labs, Inc, Pittsburgh, PA) in a neonate with single-ventricle disease. The use of dilatable conduits could change the management of many congenital heart defects and greatly reduce both the morbidity of repeat cardiac reoperations and the deleterious effects of prolonged conduit dysfunction that accrue between surgical conduit revisions.

Original language	English (US)
Pages (from-to)	e131-e133
Journal	Annals of Thoracic Surgery
Volume	110
Issue number	2
DOIs	https://doi.org/10.1016/j.athoracsur.2019.12.024
State	Published - Aug 2020

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.athoracsur.2019.12.024

Cite this

@article{1e453db0e938400ebff50318b5df7f30,

title = "Use of a Dilatable exGraft Conduit in Single-Ventricle Palliation",

abstract = "Surgically paced prosthetic conduits are commonly used in the treatment of congenital heart disease. A major limitation of available prosthetic grafts is that they do not grow with the patient. We describe a human case of percutaneous balloon dilation of a surgically placed exGraft conduit (PECA Labs, Inc, Pittsburgh, PA) in a neonate with single-ventricle disease. The use of dilatable conduits could change the management of many congenital heart defects and greatly reduce both the morbidity of repeat cardiac reoperations and the deleterious effects of prolonged conduit dysfunction that accrue between surgical conduit revisions.",

author = "Asad Qadir and Paul Tannous and Stephens, {Elizabeth H.} and Arush Kalra and Forbess, {Joseph M.} and Alan Nugent",

note = "Publisher Copyright: {\textcopyright} 2020 The Society of Thoracic Surgeons",

year = "2020",

month = aug,

doi = "10.1016/j.athoracsur.2019.12.024",

language = "English (US)",

volume = "110",

pages = "e131--e133",

journal = "Annals of Thoracic Surgery",

issn = "0003-4975",

publisher = "Elsevier USA",

number = "2",

}

TY - JOUR

T1 - Use of a Dilatable exGraft Conduit in Single-Ventricle Palliation

AU - Qadir, Asad

AU - Tannous, Paul

AU - Stephens, Elizabeth H.

AU - Kalra, Arush

AU - Forbess, Joseph M.

AU - Nugent, Alan

PY - 2020/8

Y1 - 2020/8

N2 - Surgically paced prosthetic conduits are commonly used in the treatment of congenital heart disease. A major limitation of available prosthetic grafts is that they do not grow with the patient. We describe a human case of percutaneous balloon dilation of a surgically placed exGraft conduit (PECA Labs, Inc, Pittsburgh, PA) in a neonate with single-ventricle disease. The use of dilatable conduits could change the management of many congenital heart defects and greatly reduce both the morbidity of repeat cardiac reoperations and the deleterious effects of prolonged conduit dysfunction that accrue between surgical conduit revisions.

AB - Surgically paced prosthetic conduits are commonly used in the treatment of congenital heart disease. A major limitation of available prosthetic grafts is that they do not grow with the patient. We describe a human case of percutaneous balloon dilation of a surgically placed exGraft conduit (PECA Labs, Inc, Pittsburgh, PA) in a neonate with single-ventricle disease. The use of dilatable conduits could change the management of many congenital heart defects and greatly reduce both the morbidity of repeat cardiac reoperations and the deleterious effects of prolonged conduit dysfunction that accrue between surgical conduit revisions.

UR - http://www.scopus.com/inward/record.url?scp=85088397058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088397058&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2019.12.024

DO - 10.1016/j.athoracsur.2019.12.024

M3 - Article

C2 - 31991132

AN - SCOPUS:85088397058

SN - 0003-4975

VL - 110

SP - e131-e133

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 2

ER -

Use of a Dilatable exGraft Conduit in Single-Ventricle Palliation

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this